Trial no.:
|
PACTR202212771733970 |
Date of Approval:
|
12/12/2022 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
INFLUENCE OF SENSORY INTEGRATION TRAINING ON THE SPATIO-TEMPORAL GAIT PARAMETERS IN PARKINSONIANS FOLLOWING STEREOTACTIC SURGERY |
Official scientific title |
INFLUENCE OF SENSORY INTEGRATION TRAINING ON THE SPATIO-TEMPORAL GAIT PARAMETERS IN PARKINSONIANS FOLLOWING STEREOTACTIC SURGERY |
Brief summary describing the background
and objectives of the trial
|
Parkinson's Disease (PD) is a progressive, neurodegenerative disorder. It’s mainly associated with dopamine innervation deficiency to the Corpus striatum (Nucleus caudate and Putamen) and, as a consequence, PD symptoms’ appearance –motor and non-motor.
The major motor disturbances are resting tremors, rigidity, and akinesia (often accompanied by postural instability and gait disorders), leaving an individual unable to control or direct movement.
Gait difficulties have emerged as some of the main therapeutic challenges as they impose substantial disability on PD patients, representing a milestone in the progression of the disease. PD gait disturbance is produced by a combination of multiple factors, including bradykinesia, impaired postural reflexes, abnormal postures, rigidity, and tremor and characterized by a paucity of movement of the trunk, upper-body, and lower-body muscles, resulting in slow and shuffling steps that are short and rapid, which may lead to traumatic injuries, and restriction of activities that in turn contribute to loss of independence, and increased mortality.
The objective of this study is to examine the effect of sensory integration training (SIT) on gait parameters in PD patients following stereotactic surgery |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Nervous System Diseases |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
SENSORY INTEGRATION TRAINING |
Anticipated trial start date |
27/11/2022 |
Actual trial start date |
|
Anticipated date of last follow up |
30/06/2023 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
30 |
Actual target sample size (number of participants) |
|
Recruitment status |
Active, not recruiting |
Publication URL |
|
|